BCI
TMO icon

Brinker Capital Investments’s Thermo Fisher Scientific TMO Stock Holding History

Brinker Capital Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$492 – 2111
2026
Q1 		$492 Buy
+1
New +$543 ﹤0.01% 1945

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brinker Capital Investments's TMO Position: Q2 2026 in Review

Brinker Capital Investments reduced its Thermo Fisher Scientific (TMO) stake by 4.5% in Q2 2026, selling an estimated $361K and leaving 15,760 shares worth $7.9M. The position accounts for 0.06% of the portfolio, ranked #285.

Brinker Capital Investments first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $41M in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Brinker Capital Investments held 15,760 shares of Thermo Fisher Scientific worth $7.9M as of Q2 2026.
  • Brinker Capital Investments sold 751 Thermo Fisher Scientific shares in Q2 2026, an estimated $361K.
  • Thermo Fisher Scientific made up 0.06% of Brinker Capital Investments's portfolio in Q2 2026, its #285 holding.
  • Brinker Capital Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
  • Brinker Capital Investments's Thermo Fisher Scientific position peaked at $41M in Q4 2021.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.